Article Text

Download PDFPDF
Interventional cardiac catheterisation in congenital heart disease
  1. R E Andrews,
  2. R M R Tulloh
  1. Department of Congenital Heart Disease, Guy’s and St Thomas’ Hospital, London, UK
  1. Correspondence to:
    Dr R E Andrews
    Department of Congenital Heart Disease, Guy’s and St Thomas’ NHS Trust, Guy’s Hospital, St Thomas’ Street, London SE1 9RT, UK;


As a result of recent technological advances, more types of congenital heart disease are amenable to treatment in the cardiac catheter laboratory than ever before.1 Improved imaging techniques allow for better selection of patients, and the development of a wide range of devices specifically for use in children means that many patients can avoid surgery altogether, while those with complex congenital heart disease may require fewer or less complex surgical procedures.2 This allows for a quicker recovery and a shorter hospital stay, and gives many patients an improved quality of life in the short to medium term. However, the long term outcome for many of the newer forms of intervention is still unknown.

  • ASD, atrial septal defect
  • PDA, persistent arterial duct
  • VSD, ventricular septal defect
  • atrial septal defect
  • persistent arterial duct
  • ventricular septal defect
  • congenital heart disease
  • cardiac catheterisation

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.